Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
ELDN holding history
Eledon Pharmaceuticals, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELDN overviewAll 13F holders of ELDNFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −67,743−100.0% | Sold out | Holders |
| Q4 2022 | 67,743 | $154.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 67,743 | $187.0K | <0.1% | +8,678+14.7% | Added | Holders |
| Q2 2022 | 59,065 | $144.1K | <0.1% | −54,943−48.2% | Reduced | Holders |
| Q1 2022 | 114,008 | $449.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 114,008 | $502.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 114,008 | $704.6K | 0.1% | +114,008 | New | Holders |